Common Sub-Domain::Drug

: Public Class

Created:	2/13/2008 11:03:20 AM
Modified:	8/26/2017 2:00:36 AM

Project:
Author:	BRIDG SCC
Version:	1.0
Phase:	1.0
Status:
Complexity:	Easy
Difficulty:
Priority:
Multiplicity:
Advanced:
UUID:	{C5918024-C0FF-48c8-8E2F-99A85EC9ABCF}
Appears In:	UML-Based Comprehensive BRIDG Model Diagram, View MB: Molecular Biology, View CM: Common, View IM: Imaging, Product, Imaging Acquisition, Oncology & Imaging View

DEFINITION: An article other than food intended for use in the diagnosis, cure, mitigation, treatment, or prevention of disease; or intended to affect the structure or any function of the body. EXAMPLE(S): aspirin OTHER NAME(S): NOTE(S):

Attributes
Associations From
Tagged Values
Other Links

Attribute

Public CD
actionModeCode

Details:

Alias:
Initial:
Stereotype:
Ordered:
Range:	Range:0 to 1
Transient:	False
Derived:	False
IsID:	False

Map:CTRRr3=ProductPart.actionModeCode

Notes:

DEFINITION: A coded value specifying the mode of action through which this substance produces a pharmacological effect. EXAMPLE(S): stimulating action, depressing action, blocking/antagonizing action, stabilizing action, exchanging/replacing substances, direct beneficial chemical reaction, direct harmful chemical reaction. OTHER NAME(S): NOTE(S):

Public CD
handlingCode

Details:

Alias:
Initial:
Stereotype:
Ordered:
Range:	Range:0 to 1
Transient:	False
Derived:	False
IsID:	False

Map:CTRv1.0=Drug.handlingCode
Map:ICSRr2=Product.handlingCode (in R_Product)

Notes:

DEFINITION: A coded value specifying special handling requirements for the drug. EXAMPLE(S): keep at room temperature, store upright OTHER NAME(S): NOTE(S):

Public CD
riskCode

Details:

Alias:
Initial:
Stereotype:
Ordered:
Range:	Range:0 to 1
Transient:	False
Derived:	False
IsID:	False

Map:CTRv1.0=Drug.riskCode
Map:ICSRr2=Product.riskCode (in R_Product)

Notes:

DEFINITION: A coded value specifying the type of hazard or threat associated with the drug. EXAMPLE(S): flammable, explosive OTHER NAME(S): NOTE(S):

Public IVL<TS.DATETIME>
stabilityDuration

Details:

Alias:
Initial:
Stereotype:
Ordered:
Range:	Range:0 to 1
Transient:	False
Derived:	False
IsID:	False

Map:CTRv1.0=Drug.stabilityDuration
Map:ICSRr2=ProductInstance.stabilityTime (in R_Product)

Notes:

DEFINITION: The period of time during which the drug is considered usable after it is activated (opened). EXAMPLE(S): OTHER NAME(S): NOTE(S):

Element	Source Role	Target Role
MolecularBiomarkerGroup Class	Name: affectingMolecularBiomarkerGroup	Name: affectedDrug
Details: DESCRIPTION:<br/>Each MolecularBiomarkerGroup might impact the effectiveness of one or more Drug. Each Drug might have effectiveness impacted by one or more MolecularBiomarkerGroup. <br/><br/>DEFINITION:<br/><br/>EXAMPLE(S):<br/>Molecular Biomarker Group "L10I+K20R+M36I+A71V+V82T" links a set of mutations with the conclusion of drug resistance to the drug "lndinavir".<br/><br/>OTHER NAME(S):<br/><br/>NOTE(S):<br/>

Tag	Value
Map:caAERSv2.2	ChemoAgent
Details:
Map:CDMHv1.0	Drug
Details:
Map:CTRPv1.0	Drug
Details:
Map:CTRv1.0	Drug
Details:

Object	Type	Connection	Direction	Notes
Product	Class	Generalization	To	DESCRIPTION: Each Drug always specializes one Product. Each Product might be specialized by one Drug. DEFINITION: EXAMPLE(S): OTHER NAME(S): NOTE(S):
Radiopharmaceutical	Class	Generalization	From	ESCRIPTION: Each Radiopharmaceutical always specializes one Drug. Each Drug might be specialized by one Radiopharmaceutical. DEFINITION: EXAMPLE(S): OTHER NAME(S): NOTE(S):